FATE THERAPEUTICS INC Convertible Preferred Stock, Shares Issued upon Conversion
FATE THERAPEUTICS INC (FATE) had Convertible Preferred Stock, Shares Issued upon Conversion of 7.23 million shares as of 2013-10-04, per its 10-K filed 2015-03-12.
Discontinued › Notes › Stockholders' Equity Note
us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion · last filed 2016-03-03
- 2013-10-04: Convertible Preferred Stock, Shares Issued upon Conversion 7.23M shares.
- 2013-09-13: Convertible Preferred Stock, Shares Issued upon Conversion 7.23M shares.
| Period end | Convertible Preferred Stock, Shares Issued upon Conversion |
|---|---|
| 2013-10-04 | 7.23M shares 10-K · filed 2015-03-12 |
| 2013-09-13 | 7.23M shares 10-K · filed 2016-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |